project id: TCGA-BLCA; case submitter id: TCGA-R3-A69X; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.92; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.72; rna integrity number: 7.9; age at index: 70; days to birth: -25576; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1942; age at diagnosis: 25576; ajcc clinical t: T3a; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage III; ajcc pathologic t: T3a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 433.0; icd 10 code: C67.2; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Lateral wall of bladder; synchronous malignancy: No; tissue or organ of origin: Lateral wall of bladder; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: Not Reported; cigarettes per day: 2.6301369863013697; pack years smoked: 48.0; is ffpe: false; composition: Not Reported; days to collection: 448; initial weight: 420.0; oct embedded: false; preservation method: Unknown; sample id: 311ccb15-c5d3-4e70-850a-bdf75779238c; sample submitter id: TCGA-R3-A69X-01A; portion id: 2a7835ec-ceea-47f5-8b15-a301ce19a7d9; portion submitter id: TCGA-R3-A69X-01A-22; slide id: e8d6c71c-c3b1-4364-b65a-7e4c9cb1ebba; slide submitter id: TCGA-R3-A69X-01A-02-TS2; percent lymphocyte infiltration: 4.0; percent monocyte infiltration: 1.0; percent necrosis: 2.0; percent neutrophil infiltration: 1.0; percent normal cells: 4.0; percent stromal cells: 56.0; percent tumor cells: 38.0; percent tumor nuclei: 75.0; section location: TOP;